Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

'GREAT PLEA' system proposed for responsible use of generative AI in healthcare

'GREAT PLEA' system proposed for responsible use of generative AI in healthcare

Research uncovers stealthy strategy of SARS-CoV-2 infection

Research uncovers stealthy strategy of SARS-CoV-2 infection

Government’s £2 billion plan sets out to harness the power of engineering biology

Government’s £2 billion plan sets out to harness the power of engineering biology

The past, present and future of automation and digitalization in the life sciences laboratory

The past, present and future of automation and digitalization in the life sciences laboratory

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

UK Biobank unveils world's largest genetic data set

UK Biobank unveils world's largest genetic data set

Hevolution-AFAR New Investigator Awards expanded with $16 million grant

Hevolution-AFAR New Investigator Awards expanded with $16 million grant

New drug combination may improve treatment for rare nerve sheath tumors

New drug combination may improve treatment for rare nerve sheath tumors

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

UK Biobank data opens door to new era of precision medicine

UK Biobank data opens door to new era of precision medicine

Insilico Medicine hosts three webinars to unveil latest technology breakthroughs

Insilico Medicine hosts three webinars to unveil latest technology breakthroughs

New heart organoid model could revolutionize drug development and toxicology studies

New heart organoid model could revolutionize drug development and toxicology studies

Unveiling a new cardiac myosin inhibitor through AI-driven virtual screening

Unveiling a new cardiac myosin inhibitor through AI-driven virtual screening

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

TACTIC project aims to uncover genetic causes of cancer and develop targeted therapies

TACTIC project aims to uncover genetic causes of cancer and develop targeted therapies

Circular extrachromosomal DNA identified as a potential target for new medulloblastoma therapies

Circular extrachromosomal DNA identified as a potential target for new medulloblastoma therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.